Navigation Links
Pharmaceutical Launch Excellence Services Delivers Market Entry Road Map
Date:3/4/2011

CHAPEL HILL, N.C., March 4, 2011 /PRNewswire/ -- The pressure for a new product to succeed at launch has never been greater with organizations across the pharmaceutical sector facing pipeline deficits, patent expirations and increasing development costs.

Facing an ever-changing launch landscape, product launch leaders are looking to guard against uncertainty as they guide new therapies through the labyrinth of regulatory and marketplace challenges.

To that end, Best Practices, LLC has collected hundreds of best practices, narratives, and metrics around the issue of new product launch. To provide launch executives with the critical information they need to succeed with a product launch, we have consolidated our best launch research and services into the Pharmaceutical Launch Excellence Services.

The Launch Excellence Services product connects launch professionals to benchmarking and networking solutions to address a variety of mission-critical issues, including:

  • Spend across launch activities
  • Differentiating a new product from competitors
  • Portfolio decisions
  • Timing and value of different new product planning activities
  • Coordinating Regional and Global launch activities
  • Strength and weakness of various structural approaches for new product planning
  • Balancing development and commercial interests
  • Brand team responsibilities
  • Use of public relations to support launch

Pharmaceutical executives will find the primary and secondary research information provided in this product essential for identifying trends, gaining a better understanding of the market and ensuring a strong market entry for new products.

To explore the Pharmaceutical Launch Excellence Services in greater detail, download our complimentary research excerpt at http://www3.best-in-class.com/or2.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies.  For more than 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.  For more information about the company, go to www.best-in-class.com.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
2. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2010 Financial Results
3. Endo Pharmaceuticals Launches FORTESTA™ (Testosterone) Gel for Topical Use Class III for Adult Men in the U.S. With Low Testosterone
4. Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
5. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Cowen and Company 31st Annual Health Care Conference in Boston on March 9, 2011
6. Onyx Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
7. Savient Pharmaceuticals to Present at the 31st Annual Cowen & Co. Health Care Conference
8. Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc.
9. Handa Pharmaceuticals Announces Submission of Its First-to-File ANDA for Takedas DEXILANT®
10. Auxilium Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
11. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... 11, 2017  BioPharmX Corporation (NYSE MKT: BPMX) researchers ... an innovative way to use nonlinear optical imaging to ... new drugs. ... will show how researchers from BioPharmX and the Wellman ... used a suite of imaging techniques in what is ...
(Date:10/10/2017)...   West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today shared the results of a study highlighting ... intradermal administration of polio vaccines. The study results were ... 2017 by Dr. Ondrej Mach , Clinical Trials ... (WHO), and recently published in the journal Vaccine. ...
(Date:10/4/2017)... LAWRENCE, Mass. , Oct. 4, 2017 /PRNewswire/ ... developer of single-use, self-contained, illuminating medical devices, today ... National Health Surveillance Agency (or Agência Nacional ... ®. The first single-use, cordless surgical retractor with ... ONETRAC provides optimal access, illumination and exposure of ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... process to promote standards of excellence for the field of eating disorders, announces ... 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... ... 13, 2017 , ... Many families have long-term insurance that covers care for ... a waiver for care if the client has a cognitive impairment diagnosis. , ... care, is often waived, so the benefits from their insurance start immediately,” said Mechell ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... giving viewers the lowdown on sciatica in a new episode of "Success Files," ... on current events and innovation and investigates each subject in-depth with passion and ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... AccentCare, a leader in post-acute health care, have expanded their existing home health ... Home Health. , AccentCare has been operating a joint venture home health company ...
Breaking Medicine News(10 mins):